- Home
- ESOA vs PLX Comparison
ESOA vs PLX Comparison
Compare ESOA & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESOA
- PLX
- Stock Information
- Founded
- ESOA 2006
- PLX 1993
- Country
- ESOA United States
- PLX United States
- Employees
- ESOA N/A
- PLX N/A
- Industry
- ESOA Water Sewer Pipeline Comm & Power Line Construction
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESOA Industrials
- PLX Health Care
- Exchange
- ESOA Nasdaq
- PLX Nasdaq
- Market Cap
- ESOA 135.6M
- PLX 160.2M
- IPO Year
- ESOA 2006
- PLX 1998
- Fundamental
- Price
- ESOA $9.42
- PLX $1.73
- Analyst Decision
- ESOA
- PLX Strong Buy
- Analyst Count
- ESOA 0
- PLX 1
- Target Price
- ESOA N/A
- PLX $15.00
- AVG Volume (30 Days)
- ESOA 154.3K
- PLX 1.0M
- Earning Date
- ESOA 05-20-2025
- PLX 05-09-2025
- Dividend Yield
- ESOA 0.32%
- PLX N/A
- EPS Growth
- ESOA 161.70
- PLX N/A
- EPS
- ESOA 1.44
- PLX 0.04
- Revenue
- ESOA $362,359,788.00
- PLX $59,764,000.00
- Revenue This Year
- ESOA $9.95
- PLX $65.02
- Revenue Next Year
- ESOA N/A
- PLX $57.34
- P/E Ratio
- ESOA $6.84
- PLX $40.01
- Revenue Growth
- ESOA 8.42
- PLX 0.18
- 52 Week Low
- ESOA $5.70
- PLX $0.82
- 52 Week High
- ESOA $19.83
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- ESOA 53.18
- PLX 27.30
- Support Level
- ESOA $8.31
- PLX $2.70
- Resistance Level
- ESOA $9.91
- PLX $2.93
- Average True Range (ATR)
- ESOA 0.57
- PLX 0.21
- MACD
- ESOA 0.13
- PLX -0.08
- Stochastic Oscillator
- ESOA 71.51
- PLX 0.36
About ESOA Energy Services of America Corporation
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.